Exposure to triptans during pregnancy is reported not to increase the risk of long-term neurodevelopmental outcomes in offspring. Specifically, it is said not to raise the risk of neurodevelopmental disorders, autism, or attention-deficit/hyperactivity disorder. However, the relationship between maternal health conditions and offspring neurodevelopment is also being studied in the context of other factors, such as maternal diabetes.